首站-论文投稿智能助手
典型文献
Bicyclic stapled peptides based on p53 as dual inhibitors for the interactions of p53 with MDM2 and MDMX
文献摘要:
In recent years,the strategy of inhibiting the interactions of p53 with murine double minute 2(MDM2)and murine double minute X(MDMX)has been proved to be a promising approach for tumor therapy.However,the poor proteolytical stability and low intracellular delivery efficiency of peptide inhibitors limit their clinical application.Here,we designed and synthesized the bicyclic stapled peptides based on p53 by combining all-hydrocarbon stapling and lactam stapling strategies.We demonstrated that bi-cyclic stapled peptide p53-16 significantly improved α-helicity and proteolytic stability.Especially,p53-16 showed nanomolar binding affinity for MDM2 and MDMX.In addition,p53-16 could penetrate the cell membrane,and selectively inhibited the activity of tumor cells via activating p53 pathway in vitro.Our data suggest that p53-16 is a potential dual inhibitor of MDM2 and MDMX interactions.The bicyclic sta-pling strategy is a promising drug design strategy for protein-protein interactions inhibitors.
文献关键词:
作者姓名:
Hongjin Li;Xiangyan Chen;Minghao Wu;Panpan Song;Xia Zhao
作者机构:
Key Laboratory of Marine Drugs,Ministry of Education,School of Medicine and Pharmacy,Ocean University of China,Qingdao 266003,China;Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology,Qingdao 266237,China
引用格式:
[1]Hongjin Li;Xiangyan Chen;Minghao Wu;Panpan Song;Xia Zhao-.Bicyclic stapled peptides based on p53 as dual inhibitors for the interactions of p53 with MDM2 and MDMX)[J].中国化学快报(英文版),2022(03):1254-1258
A类:
Bicyclic,stapled,MDMX,proteolytical,stapling
B类:
peptides,p53,dual,inhibitors,interactions,MDM2,In,recent,years,strategy,inhibiting,murine,double,minute,has,been,promising,approach,tumor,therapy,However,poor,stability,low,intracellular,delivery,efficiency,limit,their,clinical,application,Here,designed,synthesized,bicyclic,by,combining,hydrocarbon,lactam,strategies,We,demonstrated,that,significantly,improved,helicity,Especially,showed,nanomolar,binding,affinity,addition,could,penetrate,membrane,selectively,inhibited,activity,cells,via,activating,pathway,vitro,Our,data,suggest,potential,drug,protein
AB值:
0.445718
相似文献
Injectable hybrid inorganic nanoscaffold as rapid stem cell assembly template for cartilage repair
Shenqiang Wang;Letao Yang;Bolei Cai;Fuwei Liu;Yannan Hou;Hua Zheng;Fang Cheng;Hepeng Zhang;Le Wang;Xiaoyi Wang;Qianxin Lv;Liang Kong;Ki-Bum Lee;Qiuyu Zhang-Key Laboratory of Special Functional and Smart Polymer Materials of Ministry of industry and Information Technology,School of Chemistry and Chemical Engineering,Northwestern Polytechnical University,Xi'an 710129,China;Xi'an Key Laboratory of Functional Organic Porous Materials,School of Chemistry and Chemical Engineering,Northwestern Polytechnical University,Xi'an 710072,China;Department of Chemistry and Chemical Biology,Rutgers University,Piscataway,NJ 08854,USA;Department of Biomedical Engineering,Columbia University,New York,NY 10032,USA;State Key Laboratory of Military Stomatology&National Clinical Research Center for Oral Diseases&Shaanxi Key Laboratory of Oral Diseases,Department of Oral and Maxillofacial Surgery,School of Stomatology,The Fourth Military Medical University,Xi'an 710032,China;Research&Development Institute of Northwestern Polytechnical University in Shenzhen,Shenzhen 518057,China
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
Xianbin Ma;Shaochen Yang;Tian Zhang;Shuo Wang;Qichao Yang;Yao Xiao;Xiaoxiao Shi;Peng Xue;Yuejun Kang;Gang Liu;Zhi-Jun Sun;Zhigang Xu-Key Laboratory of Luminescence Analysis and Molecular Sensing(Southwest University),Ministry of Education,School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices,Southwest University,Chongqing 400715,China;The State Key Laboratory Breeding Base of Basic Science of Stomatology(Hubei-MOST) & Key Laboratory of Oral Biomedicine,Ministry of Education,School and Hospital of Stomatology,Wuhan University,Wuhan 430079,China;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine,School of Public Health,Xiamen University,Xiamen 361102,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
Chengliang Sun;Yao Cheng;Xiaojia Liu;Gefei Wang;Wenjian Min;Xiao Wang;Kai Yuan;Yi Hou;Jiaxing Li;Haolin Zhang;Haojie Dong;Liping Wang;Chenguang Lou;Yanze Sun;Xinmiao Yu;Hongbin Deng;Yibei Xiao;Peng Yang-State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization,China Pharmaceutical University,Nanjing 210009,China;Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Department of Pharmacology,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Beijing Institute of Clinical Pharmacy,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China;Department of Physics,Chemistry and Pharmacy,University of Southern Denmark,Campusvej 55,5230 Odense,Denmark;Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。